FI961407A0 - Rokote Branhamella catarrhalista vastaan - Google Patents

Rokote Branhamella catarrhalista vastaan

Info

Publication number
FI961407A0
FI961407A0 FI961407A FI961407A FI961407A0 FI 961407 A0 FI961407 A0 FI 961407A0 FI 961407 A FI961407 A FI 961407A FI 961407 A FI961407 A FI 961407A FI 961407 A0 FI961407 A0 FI 961407A0
Authority
FI
Finland
Prior art keywords
protein
vaccine
oligopeptides
peptides
constructing
Prior art date
Application number
FI961407A
Other languages
English (en)
Swedish (sv)
Other versions
FI961407A (fi
FI117789B (fi
Inventor
Timothy F Murphy
Original Assignee
Univ New York State Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/129,719 external-priority patent/US5556755A/en
Application filed by Univ New York State Res Found filed Critical Univ New York State Res Found
Publication of FI961407A0 publication Critical patent/FI961407A0/fi
Publication of FI961407A publication Critical patent/FI961407A/fi
Application granted granted Critical
Publication of FI117789B publication Critical patent/FI117789B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • C07K14/212—Moraxellaceae, e.g. Acinetobacter, Moraxella, Oligella, Psychrobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FI961407A 1993-09-29 1996-03-28 Menetelmä rokotteen valmistamiseksi Branhamella catarrhalista vastaan FI117789B (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US08/129,719 US5556755A (en) 1993-09-29 1993-09-29 Method for detecting Branhamella catarrhalis
US12971993 1993-09-29
US08/306,871 US5712118A (en) 1993-09-29 1994-09-20 Vaccine for branhamella catarrhalis
US30687194 1994-09-20
PCT/US1994/010932 WO1995009025A1 (en) 1993-09-29 1994-09-27 VACCINE FOR $i(BRANHAMELLA CATARRHALIS)
US9410932 1994-09-27

Publications (3)

Publication Number Publication Date
FI961407A0 true FI961407A0 (fi) 1996-03-28
FI961407A FI961407A (fi) 1996-05-21
FI117789B FI117789B (fi) 2007-02-28

Family

ID=26827856

Family Applications (1)

Application Number Title Priority Date Filing Date
FI961407A FI117789B (fi) 1993-09-29 1996-03-28 Menetelmä rokotteen valmistamiseksi Branhamella catarrhalista vastaan

Country Status (12)

Country Link
US (2) US5712118A (fi)
EP (1) EP0737085B1 (fi)
JP (1) JPH09503210A (fi)
AT (1) ATE321585T1 (fi)
AU (1) AU701340B2 (fi)
CA (1) CA2172728A1 (fi)
DE (1) DE69434681T2 (fi)
DK (1) DK0737085T3 (fi)
ES (1) ES2259792T3 (fi)
FI (1) FI117789B (fi)
PT (1) PT737085E (fi)
WO (1) WO1995009025A1 (fi)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020055101A1 (en) 1995-09-11 2002-05-09 Michel G. Bergeron Specific and universal probes and amplification primers to rapidly detect and identify common bacterial pathogens and antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories
US6001564A (en) * 1994-09-12 1999-12-14 Infectio Diagnostic, Inc. Species specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial pathogens and associated antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories
US6121427A (en) * 1994-10-24 2000-09-19 Connaught Laboratories Limited Major outer membrane protein CD of branhamella
US5994066A (en) * 1995-09-11 1999-11-30 Infectio Diagnostic, Inc. Species-specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial pathogens and associated antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories
US20030033617A1 (en) * 1996-04-10 2003-02-13 Gyula Hadlaczky Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
US6685949B1 (en) * 1998-01-13 2004-02-03 The United States Of America As Represented By The Department Of Health & Human Services Lipooligosaccharide based vaccine for prevention of moraxella (branhamella)catarrhalis infections in humans
US20030049636A1 (en) 1999-05-03 2003-03-13 Bergeron Michel G. Species-specific, genus-specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial and fungal pathogens and associated antibiotic resistance genes from clinical specimens for diagnosis in microbiology laboratories
US20100267012A1 (en) 1997-11-04 2010-10-21 Bergeron Michel G Highly conserved genes and their use to generate probes and primers for detection of microorganisms
US5972496A (en) * 1997-04-28 1999-10-26 Mobil Oil Corporation Film structure
GB9808720D0 (en) 1998-04-23 1998-06-24 Smithkline Beecham Biolog Novel compounds
GB9810084D0 (en) 1998-05-11 1998-07-08 Cortecs Uk Ltd Proteins
US6627728B1 (en) 1998-05-12 2003-09-30 Smithkline Beecham Biologicals S.A. Compounds from moraxella catarrhalis
GB9810193D0 (en) * 1998-05-12 1998-07-08 Smithkline Beecham Biolog Novel compounds
GB9810285D0 (en) 1998-05-13 1998-07-15 Smithkline Beecham Biolog Novel compounds
US6673910B1 (en) 1999-04-08 2004-01-06 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to M. catarrhalis for diagnostics and therapeutics
US6713062B1 (en) * 1999-05-17 2004-03-30 The Regents Of The University Of Michigan Acinetobacter outer membrane protein and gene sequence compositions and methods
GB9915044D0 (en) * 1999-06-25 1999-08-25 Smithkline Beecham Biolog Novel compounds
US6391313B1 (en) * 1999-07-15 2002-05-21 Aventis Pasteur Limited Multi-component vaccine to protect against disease caused by Haemophilus influenzae and Moraxella catarrhalis
GB9918038D0 (en) * 1999-07-30 1999-09-29 Smithkline Beecham Biolog Novel compounds
GB9918302D0 (en) * 1999-08-03 1999-10-06 Smithkline Beecham Biolog Novel compounds
GB9918208D0 (en) * 1999-08-03 1999-10-06 Smithkline Beecham Biolog Novel compounds
GB9918279D0 (en) * 1999-08-03 1999-10-06 Smithkline Beecham Biolog Novel compounds
GB9921691D0 (en) * 1999-09-14 1999-11-17 Smithkline Beecham Sa Novel compounds
GB9921692D0 (en) * 1999-09-14 1999-11-17 Smithkline Beecham Sa Novel compounds
BR0014370A (pt) 1999-09-28 2002-11-05 Infectio Diagnostic Inc Genes altamente conservados e seu uso para gerar sondas de ácido nucléico e preparadores de amplificação especìficos em espécie, especìfico em gênero, especìficos em famìlia, especìficos em grupo e universais para rapidamente detectar e identificar microorganismos algais, amebianos, bacterianos, fúngicos e parasitas de espécimes clìnicos para diagnose
EP2425855A1 (en) 2005-04-08 2012-03-07 Wyeth LLC Multivalent pneumococcal polysaccharide-protein conjugate composition
US7709001B2 (en) 2005-04-08 2010-05-04 Wyeth Llc Multivalent pneumococcal polysaccharide-protein conjugate composition
WO2006119983A2 (en) 2005-05-12 2006-11-16 Novartis Ag Genes and proteins of brachyspira hyodysenteriae and use of same for diagnosis and therapy
EP1929019A2 (en) * 2005-09-08 2008-06-11 Chromatin, Inc. Plants modified with mini-chromosomes
GB0607088D0 (en) 2006-04-07 2006-05-17 Glaxosmithkline Biolog Sa Vaccine
CN101821284B (zh) 2007-08-03 2014-11-19 贝林格尔·英格海姆维特梅迪卡有限公司 猪痢疾短螺旋体的基因和蛋白质及其用途
GB0720250D0 (en) 2007-10-17 2007-11-28 Univ Edinburgh Immunogenic compositions containing escherichia coli h7 flagella and methods of use thereof
EP2363407A1 (en) 2008-02-28 2011-09-07 Murdoch University Novel sequences of Brachyspira, immunogenic compositions, methods for preparation and use thereof
EP2530087B1 (en) 2008-03-27 2018-05-02 Murdoch University Sequences of brachyspira, immunogenic composition, methods for preparation and use thereof
JP5698693B2 (ja) * 2012-03-13 2015-04-08 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム 髄膜炎菌特異的抗血清に対する血清殺菌アッセイ

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4358535A (en) * 1980-12-08 1982-11-09 Board Of Regents Of The University Of Washington Specific DNA probes in diagnostic microbiology
FI64813C (fi) * 1980-12-31 1984-01-10 Ilkka Antero Palva Foerfarande foer producering av ett utvalt aeggviteaemne och vid foerfarandet anvaenda rekombinantplasmidvektorer
US4683195A (en) * 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US5124246A (en) * 1987-10-15 1992-06-23 Chiron Corporation Nucleic acid multimers and amplified nucleic acid hybridization assays using same
US5110589A (en) * 1988-09-14 1992-05-05 Arizona Technology Development Corporation Swine dysentery subunit vaccine and method
JPH04506662A (ja) * 1989-07-14 1992-11-19 アメリカン・サイアナミド・カンパニー 接合体ワクチンのためのサイトカイニンおよびホルモンのキヤリヤー
CA2075186A1 (en) * 1990-02-02 1991-08-03 Rudi Rossau Hybridization probes for the detection of branhamella catarrhalis strains
US5256536A (en) * 1990-11-09 1993-10-26 Syntex (U.S.A.) Inc. Nucleotide probe for Neisseria gonrrhoeae
US5216143A (en) * 1991-06-28 1993-06-01 Gen-Probe Products Company Nucleic acid probes to mycobacterium gordonae
US5552146A (en) * 1991-08-15 1996-09-03 Board Of Regents, The University Of Texas System Methods and compositions relating to useful antigens of Moraxella catarrhalis
US5292874A (en) * 1991-09-04 1994-03-08 Gen-Probe Incorporated Nucleic acid probes to Staphylococcus aureus
US5556755A (en) * 1993-09-29 1996-09-17 The Research Foundation Of State University Of New York Method for detecting Branhamella catarrhalis

Also Published As

Publication number Publication date
DK0737085T3 (da) 2006-08-07
ES2259792T3 (es) 2006-10-16
FI961407A (fi) 1996-05-21
WO1995009025A1 (en) 1995-04-06
EP0737085A1 (en) 1996-10-16
EP0737085B1 (en) 2006-03-29
CA2172728A1 (en) 1995-04-06
EP0737085A4 (en) 1999-04-07
AU7959394A (en) 1995-04-18
ATE321585T1 (de) 2006-04-15
JPH09503210A (ja) 1997-03-31
DE69434681D1 (de) 2006-05-18
FI117789B (fi) 2007-02-28
US5725862A (en) 1998-03-10
AU701340B2 (en) 1999-01-28
US5712118A (en) 1998-01-27
DE69434681T2 (de) 2006-11-09
PT737085E (pt) 2006-08-31

Similar Documents

Publication Publication Date Title
FI961407A0 (fi) Rokote Branhamella catarrhalista vastaan
ATE244577T1 (de) Impfstoff gegen moraxella catarrhalis
CA2230885A1 (en) Compounds and methods for immunotherapy and diagnosis of tuberculosis
MX9708438A (es) Proteina principal de la membrana externa de moraxella, de alto peso molecular.
NZ334358A (en) isolated polypeptide comprising an immunogenic portion of a M vaccine antigen, use in the treatment and diagnosis of mycobacterial infections
IL133056A0 (en) A polypeptide containing an immunogenic portion of a m tuberculosis antigen a variant thereof pharmaceutical compositions vaccines and kits containing same
MXPA01008966A (es) Vacunas contra el virus sincicial respiratorio a base de acido nucleico.
CA2093427A1 (en) Molecular clones of hiv-1 and uses thereof
NZ500540A (en) Purified proteins, fusion proteins, recombinant vector, vaccine, kit, comprising proteins from Actinobacillus pleuropneumoniae
SE9402089D0 (sv) Recombinant allergen, fragments thereof, corresponding recombinant DNA molecules, vectors and hosts containing the DNA molecules, diagnostic and therapeutic uses of said allergens and fragments
EP0294469A4 (en) VACCINES AND DIAGNOSTIC ANALYSIS FOR HAEMOPHILUS INFLUENZAE.
ATE211765T1 (de) Neue familie von proteaseinhibitoren und andere biologisch aktive substanzen
AU5776799A (en) Modified hcv peptide vaccines
AU3379693A (en) Vaccines and diagnostic assays for haemophilus influenzae
AU619826B2 (en) A synthetic vaccine against foot and mouth disease and a process for the preparation thereof
US5225193A (en) Bordetella toxin peptides and vaccines
Murphy et al. Vaccine for Moraxella catarrhalis
Murphy Timothy et al. VACCINE FOR MORAXELLA CATARRHALIS
EP0949333A4 (en) MUTANT ANTIGENS OF MEASURE VIRUS AND GENES ENCODING THEM
Clarke Differential amino acid composition of proteins in AT- and GC-rich eubacteria.
Murphy Method for detecting Branhamella catarrhalis
RU94030484A (ru) Плазмида, вектор, микроорганизм, лактобациллы, применение плазмиды и вектора
Koroev et al. Induction of Anti-Meningitis Immunity by Synthetic Peptides: II. Immunoactive Synthetic Fragments of the OpaB Protein from Neisseria meningitidis
SE457353B (sv) Pertussistoxinantigen jaemte immunanalystestsats, vaccinkomposition och intradermal hudtestkomposition med naemnda antigen
Turbyfill et al. Antigenic domains of Shigella virulence proteins

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 117789

Country of ref document: FI